Proteostasis Therapeutics, Inc.
Industry
- Biotechnology
- Pharmaceuticals
Other Names/Subsidiaries
- Yumanity Therapeutics, Inc.
Latest on Proteostasis Therapeutics, Inc.
Kronos Bio, Inc. implemented a restructuring plan in November that resulted in a 19% workforce reduction but extended its cash runway into 2026 and the company unveiled further cost cuts on 7 March t
Less than two years after going public via a reverse merger with troubled cystic fibrosis company Proteostasis Therapeutics, Inc. , Yumanity Therapeutics, Inc. is winding up its operations by selli
The ongoing financial market turmoil for biopharma has put an end to Amicus Therapeutics, Inc. ’s plan to spin out its gene therapy business in a separate publicly traded company called Caritas Ther
BioAtla, Inc. , Virios Therapeutics, Inc. and Scopus BioPharma Inc. brought the number of initial public offerings by biopharmaceutical companies in the US to 85 so far in 2020 as investors prepar